Custom Disease/Control iPSC Generation Service
Human induced pluripotent stem cells (iPSCs) have emerged as a powerful tool for studying various diseases, particularly genetic disorders. By reprogramming somatic cells into pluripotent stem cells, researchers can create patient-specific iPSCs that carry the genetic mutations associated with specific diseases. These iPSCs can then be differentiated into various cell types to study disease mechanisms, screen drugs, and develop potential therapies.
Expert scientists at Creative Biolabs are passionate about offering disease-related iPSC-derived cells/mutant iPSCs you need to release you from the stressful and excessive workload process of cell reprogramming - giving you more time to focus on research.
Fig. 1 Use of disease-relevant iPSCs to treat neurological diseases.1
Our iPSC Disease Models
- Patient-derived iPSC Disease Models
Patient-derived iPSC disease models are reprogrammed from innate somatic cells without any genetic manipulation. These models retain the genetic background of the individual and are reprogrammed to a pluripotent state, thereby providing insights into how diseases manifest in specific patient populations.
- Genetically Engineered iPSC Disease Models
Genetically engineered iPSC disease models involve genetic modifications to introduce specific mutations related to a disease. These models can be generated using techniques such as CRISPR/Cas9 or other gene-editing tools.
- Induced iPSC Disease Models
By introducing exogenous stimuli (e.g., Aβ1-42 peptide), researchers can create disease-like states in iPSC-derived cells, allowing for a better understanding of disease mechanisms, drug responses, and potential therapeutic interventions.
Our iPSC Control Models
- Healthy Control-derived iPSC Models
Healthy control-derived iPSC models are created from somatic cells (like skin or blood cells) of healthy individuals. These cells are reprogrammed into a pluripotent state, allowing them to differentiate into any cell type.
- Isogenic Control iPSC Models
Isogenic control iPSC models are derived from individuals with known genetic backgrounds. These lines are generated by either introducing specific disease-related mutations into healthy iPSCs or by correcting such mutations in patient-derived iPSCs, ensuring that no additional genetic alterations are made.
Disease Model Platforms
We are proud to provide disease-related iPSC-derived cells or mutant iPSCs with you for research use only, which significantly contribute to understanding various pathologies and the development of targeted therapies.
Neurological Diseases | Relevant Mutations | Available Cell Types |
---|---|---|
Alzheimer's disease | APOE 4/4, APOE 3/3, APOE 2/2, APOE 3/4, APOE 2/3, TREM2 KO, TREM2 R47H, APP A673V, APP A673T and PSEN M146L | NSCs, Cortical Neurons, GABAergic Neurons, Glutamatergic Neurons, Astrocytes and Microglia |
Parkinson's disease | Ataxin-3, PINK1, PARKIN, PARK2, SNCA A53T and LRRK2 | NSCs, Dopaminergic Neurons, Glutamatergic Neurons, Striatal Neurons, Astrocytes and Microglia |
Huntington's Disease | HTT 50 CAG | NSCs, Cortical Neurons, Glutamatergic Neurons, Striatal Neurons, |
Amyotrophic Lateral Sclerosis | SOD1, TDP43 and C9ORF72 | NSCs, Motor Neurons, Sensory Neurons |
Applications
- Disease Modeling
- Drug Discovery
- Toxicology Studies
Related Services
|
|
Reference
- McTague, Amy et al. "Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies." Front Genome Ed. 2021;3:630600. Distributed under Open Access license CC BY 4.0. The original image was modified.

- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)